Xu, Maolin
Zeng, Shue
Li, Fang
Liu, Guifeng
Funding for this research was provided by:
Wu Jieping Medical Foundation (320.6750.19089-40)
Jilin Scientific and Technological Development Program (20220203113SF)
National Natural Science Foundation of China (52275006)
National Cancer Center (NCC201917B04)
Article History
Received: 10 April 2023
Accepted: 5 October 2023
First Online: 2 November 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: This retrospective study was approved by the ethics committee of the Hubei Cancer Hospital (No.: LLHBCH2021YN-001).
: Written informed consent was waived by the Institutional Review Board.
: As this study was retrospective in nature, the requirement for obtaining informed consent for publication was waived.